Dr. Pizzolato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-689-6500Fax+1 305-689-6565
Summary
- Joseph Pizzolato, M.D., is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr. Pizzolato works as part of a multidisciplinary team of cancer experts and researchers. He earned his medical degree from Icahn School of Medicine at Mount Sinai, New York.
Education & Training
- University of MiamiMBA, Healthcare, 2020 - 2022
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2001
- Icahn School of Medicine at Mount SinaiClass of 1998
Certifications & Licensure
- FL State Medical License 2004 - 2026
- NY State Medical License 1999 - 2007
- NJ State Medical License 2001 - 2003
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) Start of enrollment: 2007 Sep 01
Publications & Presentations
PubMed
- 7 citationsGenome-wide host methylation profiling of anal and cervical carcinoma.Erin M Siegel, Abidemi Ajidahun, Anders Berglund, Whitney Guerrero, Steven Eschrich
Plos One. 2021-01-01 - 6 citationsPhase II Trial of Combined Modality Therapy with Myeloid Growth Factor Support in Patients with Locally Advanced Non-small Cell Lung CancerRogerio Lilenbaum, Michael Samuels, Michele Taffaro-Neskey, Mike Cusnir, Joseph Pizzolato
Journal of Thoracic Oncology. 2010-06-01 - 15 citationsIrinotecan (Campto) in the treatment of pancreatic cancer.Joseph F Pizzolato, Leonard B. Saltz
Expert Review of Anticancer Therapy. 2003-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: